27 May 2009 - Transgenomic has appointed Antonius P Schuh PhD and Michael B McNulty to its board of directors.
Dr Schuh is the founding chairman and chief executive officer of Sorrento Therapeutics (STI).
Mr McNulty is currently general manager of diagnostics at Agilent Technologies.
